BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.61 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-05-14
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.61, a 72.15% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $2.19, a 43.85% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.90, a 39.29% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $2.80.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $2.09, a 42.58% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $3.64, a 16.13% decline from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $4.34.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.61 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $2.09 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $2.12 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $2.19 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $2.19 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $3.64 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $3.71 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $3.86 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $3.90 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $4.34 10-K · filed 2025-03-14 | |||
| 2023-09-30 | $4.41 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $4.53 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $2.80 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |